These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12938058)

  • 1. [Autism of unknown aetiology].
    Holguín JA
    Rev Neurol; 2003 Aug 1-15; 37(3):259-66. PubMed ID: 12938058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone: a potential treatment for autism.
    Posey DJ; McDougle CJ
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sixty years of autism].
    van Berckelaer-Onnes IA
    Ned Tijdschr Geneeskd; 2004 May; 148(21):1024-30. PubMed ID: 15185436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autistic spectrum disorders 2: diagnosis and management.
    Jones A; Cork C; Chowdhury U
    Community Pract; 2006 Apr; 79(4):128-30. PubMed ID: 16634517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autism].
    Rogel-Ortiz FJ
    Gac Med Mex; 2005; 141(2):143-7. PubMed ID: 15892462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone use in the treatment of behavioral symptoms in children with autism.
    West L; Waldrop J
    Pediatr Nurs; 2006; 32(6):545-9. PubMed ID: 17256292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoplasia of cerebellar vermal lobules VI and VII in autism.
    Courchesne E; Yeung-Courchesne R; Press GA; Hesselink JR; Jernigan TL
    N Engl J Med; 1988 May; 318(21):1349-54. PubMed ID: 3367935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infantile autism and mirror neurons].
    Cornelio-Nieto JO
    Rev Neurol; 2009 Feb; 48 Suppl 2():S27-9. PubMed ID: 19280570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in finger length ratio between males with autism, pervasive developmental disorder-not otherwise specified, ADHD, and anxiety disorders.
    de Bruin EI; Verheij F; Wiegman T; Ferdinand RF
    Dev Med Child Neurol; 2006 Dec; 48(12):962-5. PubMed ID: 17109783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early communication development and intervention for children with autism.
    Landa R
    Ment Retard Dev Disabil Res Rev; 2007; 13(1):16-25. PubMed ID: 17326115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autism spectrum disorders in adults].
    Kan CC; Buitelaar JK; van der Gaag RJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(24):1365-9. PubMed ID: 18664213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders.
    Landa RJ; Holman KC; Garrett-Mayer E
    Arch Gen Psychiatry; 2007 Jul; 64(7):853-64. PubMed ID: 17606819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacology in autism: an update.
    Canitano R; Scandurra V
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):18-28. PubMed ID: 21034789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders.
    Endo T; Shioiri T; Kitamura H; Kimura T; Endo S; Masuzawa N; Someya T
    Biol Psychiatry; 2007 Nov; 62(9):1030-7. PubMed ID: 17631869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of pretend play and communication development in children with autism.
    Blanc R; Adrien JL; Roux S; Barthélémy C
    Autism; 2005 Jul; 9(3):229-45. PubMed ID: 15937039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.